STOCKHOLDERS EQUITY (Details) |
6 Months Ended |
|---|---|
|
Jun. 30, 2026
$ / shares
shares
| |
| STOCKHOLDERS EQUITY | |
| Number of options outstanding, Begging balance | shares | 500,000 |
| Number of options outstanding, Ending balance | shares | 500,000 |
| Number of options exercisable, Ending balance | shares | 500,000 |
| Weight average exercise price, Begging balance | $ 10.00 |
| Weight average exercise price, Granted | 0 |
| Weight average exercise price, Exercised | 0 |
| Weight average exercise price, Forfeited/canceled | 0 |
| Weight average exercise price, Ending balance | 10.00 |
| Weight average exercise price, Exercisable, Ending balance | $ 10.00 |
| Weighted average remaining life (years) | 9 years 3 months 18 days |
| Weighted average remaining life (years), outstanding | 8 years 9 months 18 days |
| Weighted average remaining life (years), Exercisable | 8 years 9 months 18 days |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average price at which option holders acquired shares when converting their stock options into shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|